Come up with a name for your new list and we'll add to it:
Synthecon raised a round of funding on January 22, 2009. Investors include
National Science Foundation.
Synthecon is a company that received a SBIR Phase I grant for a project entitled: Agonist-mimetic Aptamers. Their research develops an efficient method to produce single-stranded DNAs, known as aptame…